OPRL1 抗体 (AA 1-47) (AbBy Fluor® 647)
Our Local Distributor
北京 101111
Quick Overview for OPRL1 抗体 (AA 1-47) (AbBy Fluor® 647) (ABIN908605)
抗原
See all OPRL1 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 1-47
-
交叉反应
- 人, 小鼠, 大鼠
-
预测反应
- Dog,Cow,Pig,Horse,Guinea Pig
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from mouse Nociceptin receptor
-
亚型
- IgG
-
-
anti-Opiate Receptor-Like 1 (OPRL1) (AA 1-47) antibody
OPRL1 适用: 人, 小鼠, 大鼠 WB, ELISA, IF (cc), IF (p), ICC, IHC (fro), IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 323-370) antibodyOPRL1 适用: 人 WB, ELISA, IF 宿主: 兔 Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (Middle Region) antibodyOPRL1 适用: 人, 小鼠, 大鼠, Cow, 犬, 豚鼠, 山羊, 马, 兔, 绵羊, 斑马鱼 WB 宿主: 兔 Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 110-212) antibodyOPRL1 适用: 人 WB, ELISA 宿主: 小鼠 Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (C-Term) antibodyOPRL1 适用: 人, 小鼠, 大鼠 WB, ELISA, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 1-370) antibodyOPRL1 适用: 人 WB 宿主: 兔 Polyclonal unconjugated
anti-Opiate Receptor-Like 1 (OPRL1) (AA 110-212) antibodyOPRL1 适用: 人 ELISA 宿主: 小鼠 Monoclonal 2A11 unconjugated
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- OPRL1 (Opiate Receptor-Like 1 (OPRL1))
-
别名
- Nociceptin receptor
-
背景
-
Synonyms: KOR3, ORGC, ORL1, Oprl, XOR1, morc, KOR-3, LC132, MOR-C, Nociceptin receptor, K3 opiate receptor, Kappa-type 3 opioid receptor, Orphanin FQ receptor, Oprl1, Oor
Background: G-protein coupled opioid receptor that functions as receptor for the endogenous neuropeptide nociceptin. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling via G proteins mediates inhibition of adenylate cyclase activity and calcium channel activity. Arrestins modulate signaling via G proteins and mediate the activation of alternative signaling pathways that lead to the activation of MAP kinases. Plays a role in modulating nociception and the perception of pain. Plays a role in the regulation of locomotor activity by the neuropeptide nociceptin.
-
基因ID
- 18389
-
UniProt
- P35377
抗原
-
